SK Biopharmaceuticals. (326030.KQ) Q4 2023 Earnings

29JanConfirmed
Feb 22
May 22
Aug 22
Q4 2023
-579.77
-185.92
207.93
601.77

Details

Expected EPS
48.753610752
Actual EPS
114.365755392
Surprise EPS
65.61
Surprise Percent
+134.58%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 114.365755392 per share for Q4 2023.

0 Comments

Share your thoughts